|
BDTX Black Diamond Therapeutics Inc 1701541 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-9,905,000.00 |
| Balance Sheet |
|
Current Assets
|
$115,394,000.00 |
|
Assets
|
$125,029,000.00 |
|
Current Liabilities
|
$15,843,000.00 |
|
Liabilities
|
$28,938,000.00 |
|
Equity
|
$96,091,000.00 |
|
Shares Out
|
57446349.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-18,200,000.00 |
|
Investing Cash Flow
|
$16,376,000.00 |
| Market Analysis |
Market Cap
|
$123,509,650.35 |
|
Price
|
$1.96 |
|
BVPS
|
1.67 |
|
PB
|
1.29 |
|
EPS
|
-0.17 |
|
FCF
|
$-18,200,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:51 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:41 |
|
| Apr |
May |
Jun |
| 2026-03-16 |
-0.27 |
|
|
2026-05-07 |
-0.16 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-07 |
-0.19 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-06 |
-0.15 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view BDTX documents filed with the SEC.
BDTX Filings
Clear
